Halal Nutraceuticals & Vaccines Market
Increasing preference for clean-label products to drive demand for halal nutraceuticals and vaccines
Halal Nutraceuticals & Vaccines Market by Product Type, Distribution Channel, Application & Region - Forecast 2022 - 2032
Halal Nutraceuticals & Vaccines Market Snapshot (2022-2032)
[288 Pages Report] The global halal nutraceuticals & vaccines market size is expected to be valued at US$ 62,510.5 Million in 2022. Halal Nutraceuticals & Vaccines are an essential domestic commodity that have permeated into almost every section of society, leading to a robust and growing global Halal Nutraceuticals & Vaccines market.
The overall demand for halal nutraceuticals & vaccines is projected to grow at a CAGR of 7.7% between 2022 and 2032, totalling around US$ 131,253.4 Million by 2032.
|
Data Points |
Key Statistics |
|
Halal Nutraceuticals & Vaccines Market Value 2022 |
US$ 62,510.5 Million |
|
Halal Nutraceuticals & Vaccines Market Projected Value (2032) |
US$ 131,253.4 Million |
|
Halal Nutraceuticals & Vaccines Market CAGR (2022-2032) |
7.7% |
Let us know your requirement to get
100% FREE customization
Halal Nutraceuticals & Vaccines Demand Analysis (2016 To 2021) Vs Market Outlook (2022 To 2032)
From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 6.5%. Demand for halal products in the vast Muslim population countries, which is bolstering the market growth.
Manufacturers are tapping into the markets with increasing Muslim population such as Indonesia, Malaysia, Singapore and other countries of Asia Pacific excluding Japan (APEJ).
High demand for halal certified products across APEJ is expected to propel the market demand, with a market index of more than 6.2 during the forecast period. More than 80% of the global halal nutraceuticals & vaccines market revenue are anticipated to be accounted by Middle East & Africa (MEA) and APEJ collectively.
Government initiatives and campaigns undertaken for encouraging halal products also will benefit the market. Growth prospects are likely to remain positive over the coming years, supported by increasing demand for halal dietary supplements.
Hospital pharmacies and retail pharmacies will exhibit high demand. The overall demand for Halal Nutraceuticals & Vaccines is projected to grow at a CAGR of 7.7% between 2022 and 2032, totalling around US$ 131,253.4 Million by 2032.
Which Drivers Underpin Halal Nutraceuticals & Vaccines Industry Expansion?
Favorable Policies & Increasing Demand from Muslim Population to Spur Sales
Government initiatives across the globe undertaken to promote the consumption of halal products have improved the demand. Also, with increasing demand from the Muslim population will spur the demand for halal dietary supplements.
As per the World and Population Trends, by 2030, the world’s Muslim population is anticipated to reach over 2.2 billion people across the globe. With growing awareness about the halal ingredients combined with prevalence of lifestyle disorders, people are opting for halal dietary supplements such as general wellbeing, weight loss and others.
Rising initiatives from government in various countries with a vast Muslim population & encouraging investments in production of halal products will improve the growth. Also, adoption of uniform certification for halal products & increasing funds across Malaysia, India, Singapore, and other Asia Pacific excluding Japan (APEJ) countries will accelerate the growth over the forecast period.
For instance, the government in Malaysia under the association of the Ministry of International Trade & Industry developed the halal products & services to promote the halal products and make the country a halal hub. Such initiatives are anticipated to bolster the market growth and provide lucrative revenue for the market players, specifically across APEJ and MEA.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors Are Limiting The Growth Of The Halal Nutraceuticals & Vaccines Market?
High Cost Production & Lack of Acceptance will impede the Halal Nutraceuticals & Vaccines Market Growth
Acceptance of halal nutraceuticals & vaccines will remain higher across China, Malaysia, and other regions of Asia Pacific excluding Japan and Middle East & Africa. However, the demand for halal products will remain stagnant across the U.S., Germany, the U.K and other European countries.
The U.S. being the largest exporter of the halal products, sluggish growth across the country will impact the market negatively. High cost production of the halal dietary supplements and lack of acceptance in European countries might restrict the growth.
Due to lack of awareness & acceptance, high presence of substitute of halal products is hampering the demand. Lack of universal acceptance and high cost for halal certification are urging the market players to adopt alternative ingredients for nutraceuticals & vaccines.
With stringent rules in compliance with halal methods, production of halal nutraceuticals & vaccines has become an intricate task for manufacturers. This, in turn, urges them to indulge in more technological advancements, increasing the cost of production.
Hence, manufacturers are shying away when it comes to producing dietary supplements and other products through halal methods, curbing the production. As a result, these factors are affecting the halal nutraceuticals & vaccines market negatively.
Region-Wise Insights
Will North America Continue Dominance in the Global Halal Nutraceuticals & Vaccines Market?
Halal Nutraceuticals & Vaccines suppliers across the U.S. to favor the sales in the region
The North America Halal Nutraceuticals & Vaccines market is expected to accumulate a market share of 24% in 2022. On a geographic basis, the US is anticipated to be the one of the largest Halal Nutraceuticals & Vaccines markets due to the presence of a lot of exporters.
How big is the Halal Nutraceuticals & Vaccines Market in the U.A.E?
Regulatory policies across the country to continue to drive the demand
The U.A.E is anticipated to be the largest halal nutraceuticals & vaccines market over the forecast period, estimates Future Market Insights. U.A.E is one of the top countries ranked with maximum Muslim pharmaceutical consumers.
Halal nutraceuticals & vaccines suppliers across the U.S. and other countries are advised to consult with local importers prior to shipping to verify the application and halal certification of productions to the U.A.E., says the Food & Agricultural Import Regulations and Standards 2020.
The report also states that products and dietary supplements exported from any other countries such as the U.S. should comply with all the halal labeling requirements. The policy states that the product should have halal certification that must include logo of the approved U.S. Islamic organization, port of loading, production & expiry date, importer & exporter name, slaughtering date and other few strict regulations.
The U.A.E government has made the rules stricter to recover the economy from the loss suffered due to the pandemic. As the economy in the UAE is highly dependent upon travel & tourism, including food & beverages, contributing roughly 10% of GDP.
The government have reduced the import-export taxes and as it has one of the largest Muslim population, the regulatory norms have become stricter for halal products. With the stricter regulations, exporters as well as importers must receive UAE approval for their dietary supplements & food additives and identify them on the product label as halal.
How will the Demand for Halal Nutraceuticals & Vaccines soar in Japan?
Application in immune & digestive health across Japan to Propel Growth
The halal nutraceuticals & vaccines market across Japan is anticipated to witness a sluggish growth over the forecast period owing to the high cost production for the halal products. Lack of acceptance to halal products is expected to limit the market growth.
High production cost for halal compliance and increasing consumption of halal ingredients substitutes will also curb the production of halal nutraceuticals & vaccines in the pharmaceutical industry.
As per the FMI’s analysis, general wellbeing is anticipated to be the largest application in Japan, while the immune & digestive health segment stood at the second position in terms of application. Application in immune & digestive health across Japan is anticipated to account for over 22.7% market share over the forecast period.
How is the Demand for Halal Nutraceuticals & Vaccines Products Soaring across Indonesia?
Favourable regulatory policies combined with the rising preference for halal dietary supplements to propel growth
As per the International Trade Administration, the Indonesia’s Ministry of Religion in October 2020 issued a regulatory policy via decree number 464 a list of 48 types of products that mandates the halal certification. As per the policy, the government imposed the norms that the products such as fats, oils, supplements, milk, sugar, and other bakery food items must obtain halal certifications.
Halal nutraceuticals & vaccines industry players, due to the regulatory policies, are compelled to either obtain halal certification or display the label that their products are not halal.
The latter choice affects the product sales hence market players are scurrying to get the halal certification for the products, which is boosting the market demand. The halal law in the country implementing regulations enacted in October 2019 and will become mandatory starting from October 2024.
The favorable regulatory policies across the country combined with the rising preference for halal dietary supplements will aid the market growth over the coming years. Since the past few years, Indonesia ranks third in terms of Muslim pharmaceutical expenditure, and is estimated as one of the largest halal food spending country, states World Population Review.
As the fourth most populous country across the globe, with maximum Muslim population, Indonesia is a lucrative market for the halal nutraceuticals & vaccines market players. As per Future Market Insights, Indonesia is anticipated to be one of the most lucrative countries propelling growth in Asia Pacific excluding Japan.
What are the Key Factors Enabling Growth in China?
Health benefits of halal supplements to increase sales in the region
China is expected to be one of the most lucrative markets across Asia Pacific excluding Japan, registering a market share of 2.5% by 2032, estimates Future Market Insights. Demand for halal nutraceuticalss and vaccines will continue to be associated with acceptance of halal methods over others. Demand for halal beauty supplements have urged the pharmaceutical & nutraceuticals companies in China to adhere to the guidelines of halal products & processes.
Take for example, Shaanxi Virgin Element Biotech Co. Ltd. and Shandong Yuwang Pharmaceuticals Co. Ltd., both the companies have been producing halal vitamins OEM softgel supplement and vitamin halal kosher supplements for the past few decades.
Due to health benefits of halal supplements and other advantages industry players have increased the uptake of halal dietary supplements across the country catering consumer requirements. High prevalence of nutraceuticals & pharmaceutical companies in China producing and promoting the halal products have accelerated the market demand.
Companies such as Jiangsu Handian Biotechnology Co. Ltd., Hebei Xianri Biotechnology Co. Ltd., Shandong Yuwang Pharmaceutical Co. Ltd and others are increasing the production of halal gummy vitamins supplements across the country, generating lucrative revenues.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-Wise Insights
What is Affecting Halal Dietary Supplements Demand?
Rising prevalence of lifestyle disorders to boost the market growth
Demand for halal dietary supplements is expected to remain higher in China, Malaysia, Dubai, and other MEA countries. Dietary supplements contain ingredients such as fish oil, protein and calcium, which are not halal.
Hence, consumer preference for halal dietary supplements such as weight loss, or immunity boosting supplements will augment the market growth. Surging muslim population and increasing initiatives by government for the promotion and production of halal products will boost the growth.
Across the globe, muslim population accounts for 24% of the world population, which is 1.8 billion as of 2020, as per the national statistics of nations online project report. Hence, with rising prevalence of lifestyle disorders such as diabetes, thyroid and other, demand for halal dietary supplements is burgeoning.
Which Distribution Channel will hold the Lead in Halal Nutraceuticals & Vaccines Market?
Hospital pharmacies to turn out as a dominating segment
While hospital pharmacies are currently the dominating segment, supermarkets segment will register an impressive demand, accounting for over 12.71% of market share by 2022.
Hospital pharmacies are anticipated to grow substantially during the forecast period due to the expansion of the healthcare industry and increasing production of halal products & vaccines across the globe.
With the increasing consolidation of healthcare industry giants and research & development activities for the manufacturing of halal dietary supplements, the segment is expected to register demand.
Which Application will Exhibit High Demand in Halal Nutraceuticals & Vaccines Market?
General wellbeing application segment is anticipated to register positive growth
In terms of application, the market is segmented into sports nutrition, general wellbeing, immune & digestive health, bone & joint health, heart health, disease prevention, and weight loss. Future Market Insights forecasts, general wellbeing is expected to be the largest application contributing to the demand of halal nutraceuticals & vaccines. The segment growth is expected to bolster due to growing consumer demand across Japan.
General wellbeing application segment is anticipated to register positive growth, accounting for over US$ 41 Million through 2022. Immune and digestive is anticipated to be the second-largest segment after general wellbeing, backed by the high demand for halal dietary supplements. Rising demand for halal certified products such as supplements containing fish oil, protein are supporting the general wellbeing segment growth.
With the unprecedented outbreak of COVID-19, the demand for COVID-19 vaccine has burgeoned across the globe. Governments and religious leaders in Muslim-majority nations are issuing guidance, raising concerns over the process.
As per the report of Hackensack Meridian Health, Pfizer-BioNTech disclosed the ingredients of Covid-19, which included mRNA molecules containing genetic material and lipids that contain cells, which aren’t halal. The process and production of vaccine is still under scrutiny of Muslim scholar. Hence, demand for halal vaccines for general well-being is accelerating.
With the growing cases of obesity and rising prevalence of lifestyle disorders, populations with overweight are increasing the consumption of weight loss supplements.
In most of the Western European countries such as the U.K., Germany and across China, Malaysia, Singapore, increasing consumer demand for halal weight loss supplements have bolstered. As such, growth of the weight loss segment is estimated to grow at over 4.8% CAGR over the forecast period, as per FMI’s analysis.
The Start-Up Ecosystem
How Key Players are Opening Frontiers for Future Growth?
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, merger and acquisitions, partnerships and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
- Originally launched in Switzerland in 2007, Aeronutrix Sports Products made its way to the Indian market in 2015. Its flagship brand Fast&Up, headquartered in Mumbai with a presence in cities like Bengaluru and Hyderabad, is backed by innovative Swiss technology and effervescent science aimed at promoting ‘active living’.
Who are the Leading Players in the Halal Nutraceuticals & Vaccines Market?
Prominent players in the Halal Nutraceuticals & Vaccines market are Abbott Laboratories, Nestlé, Amway, Herbalife International of America, Inc., AJ Biologics Sdn Bhd., and Agropur, Inc.
- Herbalife Nutrition operates in more than 90 countries with over 10,000 employees around the world. The products are available exclusively through educated and trained independent Herbalife Nutrition distributors who provide comprehensive and personalized solutions to their customers’ nutrition and wellness goals. This person-to-person, high-touch experience is critical to the brand's mission to improve the nutritional habits of its communities and is what positively differentiates it.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 7.7% from 2022-2032 |
|
Market Value in 2022 |
US$ 62,510.5 Million |
|
Market Value in 2032 |
US$ 131,253.4 Million |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
Key Segments Covered In The Halal Nutraceuticals & Vaccines Industry Analysis
By Product Type:
- Halal Dietary Supplements
- Halal Vaccines
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Super Markets
By Application:
- Sports Nutrition
- General Wellbeing
- Immune & Digestive Health
- Bone & Joint Health
- Heart Health
- Disease Prevention
- Weight Loss
By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- Asia Pacific excluding Japan
- Japan
- Middle East and Africa (MEA)
Frequently Asked Questions
As of 2022, the Halal Nutraceuticals & Vaccines market is slated to reach a valuation of US$ 62510.5 Million
From 2022-2032, sales of Halal Nutraceuticals & Vaccines is expected to grow at a 7.7% CAGR
By 2032, Future Market Insights expects the Halal Nutraceuticals & Vaccines market to reach US$ 131253.4 Million
Table of Content
1. Executive Summary
2. Market Overview
2.1. Market Definition
2.2. Market Taxonomy
2.3. Market Introduction
2.4. Supply Chain Analysis
2.5. Global Population Vs. Muslim Population
2.6. Muslim Country Purchasing Power
3. Global Market Dynamics
3.1. Macro-economic Factors
3.2. Drivers
3.2.1. Supply Side
3.2.2. Demand Side
3.3. Restraints
3.4. Opportunity
3.5. Trends
4. Global Market Forecast
4.1. Introduction
4.1.1. Market Value
4.1.2. Absolute $ Opportunity
5. Global Market Forecast, By Product
5.1. Introduction
5.1.1. Market Value Share & BPS Analysis
5.1.2. Market Value & Y-o-Y Growth
5.2. Vaccines Product Type
5.2.1. Absolute $ Opportunity
5.2.2. Market Value
5.3. Dietary Supplements Product Type
5.3.1. Absolute $ Opportunity
5.3.2. Market Value
5.4. Global Market Attractiveness, By Product
6. Global Market Forecast, By Distribution Channel
6.1. Introduction
6.1.1. Market Value Share & BPS Analysis
6.1.2. Market Value & Y-o-Y Growth
6.2. Hospital Pharmacies Distribution Channel Type
6.2.1. Absolute $ Opportunity
6.2.2. Market Value
6.3. Retail Pharmacies Distribution Channel Type
6.3.1. Absolute $ Opportunity
6.3.2. Market Value
6.4. Online Sales Distribution Channel Type
6.4.1. Absolute $ Opportunity
6.4.2. Market Value
6.5. Super Markets Distribution Channel Type
6.5.1. Absolute $ Opportunity
6.5.2. Market Value
6.6. Global Market Attractiveness, By Distribution Channel
7. Global Market Forecast, By Applications
7.1. Introduction
7.1.1. Market Value Share & BPS Analysis
7.1.2. Market Value & Y-o-Y Growth
7.2. Sports Nutrition Application Type
7.2.1. Absolute $ Opportunity
7.2.2. Market Value
7.3. General Well-Being Application Type
7.3.1. Absolute $ Opportunity
7.3.2. Market Value
7.4. Immune & Digestive Health Application Type
7.4.1. Absolute $ Opportunity
7.4.2. Market Value
7.5. Bone & Joint Health Application Type
7.5.1. Absolute $ Opportunity
7.5.2. Market Value
7.6. Heart Health Application Type
7.6.1. Absolute $ Opportunity
7.6.2. Market Value
7.7. Disease Prevention Application Type
7.7.1. Absolute $ Opportunity
7.7.2. Market Value
7.8. Weight Loss Application Type
7.8.1. Absolute $ Opportunity
7.8.2. Market Value
7.9. Global Market Attractiveness, By Applications
8. Global Market Forecast, By Region
8.1. Introduction
8.1.1. Market Value Share & BPS Analysis
8.1.2. Market Value & Y-o-Y Growth
8.2. Market Size (US$ Mn) Forecast by Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Western Europe
8.2.4. Eastern Europe
8.2.5. Asia Pacific Excluding Japan
8.2.6. Japan
8.2.7. Middle East & Africa
8.3. Global Market Attractiveness, By Applications
9. North America Market Forecast
9.1. Introduction
9.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
9.1.2. Y-o-Y Growth Projections, By Country
9.2. North America Market Forecast, By Country
9.2.1. U.S.
9.2.2. Canada
9.3. North America Market Forecast, By Product
9.3.1. Vaccines
9.3.2. Dietary Supplements
9.4. North America Market Forecast, By Distribution Channel
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Sales
9.4.4. Super Markets
9.5. North America Market Forecast, By Applications
9.5.1. Sports Nutrition
9.5.2. General Well-Being
9.5.3. Immune & Digestive Health
9.5.4. Bone & Joint Health
9.5.5. Heart Health
9.5.6. Disease Prevention
9.5.7. Weight Loss
9.6. North America Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Distribution Channel
9.6.3. By Application
9.6.4. By Country
10. Latin America Market Forecast
10.1. Introduction
10.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
10.1.2. Y-o-Y Growth Projections, By Country
10.2. Latin America Market Forecast, By Country
10.2.1. Argentina
10.2.2. Brazil
10.2.3. Mexico
10.2.4. Rest of Latin America
10.3. Latin America Market Forecast, By Product
10.3.1. Vaccines
10.3.2. Dietary Supplements
10.4. Latin America Market Forecast, By Distribution Channel
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Sales
10.4.4. Super Markets
10.5. Latin America Market Forecast, By Applications
10.5.1. Sports Nutrition
10.5.2. General Well-Being
10.5.3. Immune & Digestive Health
10.5.4. Bone & Joint Health
10.5.5. Heart Health
10.5.6. Disease Prevention
10.5.7. Weight Loss
10.6. Latin America Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Distribution Channel
10.6.3. By Application
10.6.4. By Country
11. Western Europe Market Forecast
11.1. Introduction
11.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
11.1.2. Y-o-Y Growth Projections, By Country
11.2. Western Europe Market Forecast, By Country
11.2.1. Germany
11.2.2. France
11.2.3. U.K.
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Western Europe
11.3. Western Europe Market Forecast, By Product
11.3.1. Vaccines
11.3.2. Dietary Supplements
11.4. Western Europe Market Forecast, By Distribution Channel
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Sales
11.4.4. Super Markets
11.5. Western Europe Market Forecast, By Applications
11.5.1. Sports Nutrition
11.5.2. General Well-Being
11.5.3. Immune & Digestive Health
11.5.4. Bone & Joint Health
11.5.5. Heart Health
11.5.6. Disease Prevention
11.5.7. Weight Loss
11.6. Western Europe Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Distribution Channel
11.6.3. By Application
11.6.4. By Country
12. Eastern Europe Market Forecast
12.1. Introduction
12.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
12.1.2. Y-o-Y Growth Projections, By Country
12.2. Eastern Europe Market Forecast, By Country
12.2.1. Turkey
12.2.2. Russia
12.2.3. Rest of Eastern Europe
12.3. Eastern Europe Market Forecast, By Product
12.3.1. Vaccines
12.3.2. Dietary Supplements
12.4. Eastern Europe Market Forecast, By Distribution Channel
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Sales
12.4.4. Super Markets
12.5. Eastern Europe Market Forecast, By Applications
12.5.1. Sports Nutrition
12.5.2. General Well-Being
12.5.3. Immune & Digestive Health
12.5.4. Bone & Joint Health
12.5.5. Heart Health
12.5.6. Disease Prevention
12.5.7. Weight Loss
12.6. Eastern Europe Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.6.3. By Application
12.6.4. By Country
13. APEJ Market Forecast
13.1. Introduction
13.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
13.1.2. Y-o-Y Growth Projections, By Country
13.2. APEJ Market Forecast, By Country
13.2.1. Malaysia
13.2.2. Singapore
13.2.3. Indonesia
13.2.4. Brunei
13.2.5. India
13.2.6. Pakistan
13.2.7. Rest of APEJ
13.3. AEPJ Market Forecast, By Product
13.3.1. Vaccines
13.3.2. Dietary Supplements
13.4. APEJ Market Forecast, By Distribution Channel
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Sales
13.4.4. Super Markets
13.5. APEJ Market Forecast, By Applications
13.5.1. Sports Nutrition
13.5.2. General Well-Being
13.5.3. Immune & Digestive Health
13.5.4. Bone & Joint Health
13.5.5. Heart Health
13.5.6. Disease Prevention
13.5.7. Weight Loss
13.6. APEJ Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Distribution Channel
13.6.3. By Application
13.6.4. By Country
14. Japan Market Forecast
14.1. Introduction
14.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
14.1.2. Y-o-Y Growth Projections, By Country
14.2. Japan Market Forecast, By Product
14.2.1. Vaccines
14.2.2. Dietary Supplements
14.3. Japan Market Forecast, By Distribution Channel
14.3.1. Hospital Pharmacies
14.3.2. Retail Pharmacies
14.3.3. Online Sales
14.3.4. Super Markets
14.4. Japan Market Forecast, By Applications
14.4.1. Sports Nutrition
14.4.2. General Well-Being
14.4.3. Immune & Digestive Health
14.4.4. Bone & Joint Health
14.4.5. Heart Health
14.4.6. Disease Prevention
14.4.7. Weight Loss
14.5. Japan Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By Distribution Channel
14.5.3. By Application
14.5.4. By Country
15. MEA Market Forecast
15.1. Introduction
15.1.1. Market Value Forecast & Basis Point Share (BPS) Analysis, By Country
15.1.2. Y-o-Y Growth Projections, By Country
15.2. MEA Market Forecast, By Product
15.2.1. Vaccines
15.2.2. Dietary Supplements
15.3. MEA Market Forecast, By Country
15.3.1. Egypt
15.3.2. U.A.E.
15.3.3. North Africa
15.3.4. Saudi Arabia
15.3.5. Jordan
15.3.6. Rest of MEA
15.4. MEA Market Forecast, By Distribution Channel
15.4.1. Hospital Pharmacies
15.4.2. Retail Pharmacies
15.4.3. Online Sales
15.4.4. Super Markets
15.5. MEA Market Forecast, By Applications
15.5.1. Sports Nutrition
15.5.2. General Well-Being
15.5.3. Immune & Digestive Health
15.5.4. Bone & Joint Health
15.5.5. Heart Health
15.5.6. Disease Prevention
15.5.7. Weight Loss
15.6. MEA Market Attractiveness Analysis
15.6.1. By Product
15.6.2. By Distribution Channel
15.6.3. By Application
15.6.4. By Country
16. Major Halal Certifying Agencies, By Region
16.1. North America
16.2. Latin America
16.3. Western Europe
16.4. Eastern Europe
16.5. Asia Pacific
16.6. Middle East & Africa
17. Competitive Landscape
17.1. Competitive Dashboard
17.2. Company Profiles
17.2.1. Chemical Company of Malaysia Berhad
17.2.2. Abbott Laboratories
17.2.3. Nestlé
17.2.4. Amway
17.2.5. Herbalife International of America, Inc.
17.2.6. AJ Biologics Sdn Bhd.
17.2.7. Agropur, Inc. (Davisco Business Unit)
17.2.8. PT Kalbe Farma Tbk
17.2.9. Kotra Pharma (M) Sdn Bhd
17.2.10. NoorVitamins
18. Research Methodology
19. Assumptions & Acronyms
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Value (US$ Mn) Forecast, 2021–2031
Table 02: Global Market Value (US$ Mn) Forecast By Product, 2021–2031
Table 03: Global Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 04: Global Market Value (US$ Mn) Forecast By Applications, 2021–2031
Table 05: Global Market Value (US$ Mn) Forecast By Region, 2021–2031
Table 06: North America Market Value (US$ Mn) Forecast By Country, 2021–2031
Table 07: North America Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 08: North America Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 09: North America Market Value (US$ Mn), Forecast By Application, 2021–2031
Table 10: Latin America Market Value (US$ Mn) Forecast By Country, 2021–2031
Table 11: Latin America Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 12: Latin America Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 13: Latin America Market Value (US$ Mn), Forecast By Application, 2021–2031
Table 14: Western Europe Market Value (US$ Mn) Forecast By Country, 2021–2031
Table 15: Western Europe Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 16: Western Europe Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 17: Western Europe Market Value (US$ Mn), Forecast By Application, 2021–2031
Table 18: Eastern Europe Market Value (US$ Mn) Forecast By Country, 2021–2031
Table 19: Eastern Europe Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 20: Eastern Europe Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 21: Eastern Europe Market Value (US$ Mn), Forecast By Application, 2021–2031
Table 22: APEJ Market Value (US$ Mn) Forecast By Country, 2021–2031
Table 23: APEJ Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 24: APEJ Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 25: APEJ Market Value (US$ Mn), Forecast By Application, 2021–2031
Table 26: Japan Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 27: Japan Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 28: Japan Market Value (US$ Mn), Forecast By Application, 2021–2031
Table 29: MEA Market Value (US$ Mn) Forecast By Country, 2021–2031
Table 30: MEA Market Value (US$ Mn) Forecast By Product Type, 2021–2031
Table 31: MEA Market Value (US$ Mn) Forecast By Distribution Channel, 2021–2031
Table 32: MEA Market Value (US$ Mn), Forecast By Application, 2021–2031
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Absolute $ Opportunity (US$ Bn), 2021–2031
Figure 02: Global Market Value Share and BPS Analysis By Product Type, 2021–2031
Figure 03: Global Market Y-o-Y Growth Comparison By Product Type, 2021–2031
Figure 04: Global Market Value (US$ Mn) Forecast Vaccines 2021–2031
Figure 05: Global Urinary Tract Infection Treatment Market Absolute $ Opportunity (US$ Mn), Dietary Supplements 2021–2031
Figure 06: Global Market Attractiveness Analysis By Product Type, 2021–2031
Figure 07: Global Market Value Share and BPS Analysis By Distribution Channel, 2021–2031
Figure 08: Global Market Y-o-Y Growth Comparison By Distribution Channel, 2021–2031
Figure 09: Global Market Absolute $ Opportunity (US$ Mn), Hospital Pharmacies, 2021–2031
Figure 10: Global Market Absolute $ Opportunity (US$ Mn), Retail Pharmacies, 2021–2031
Figure 11: Global Market Absolute $ Opportunity (US$ Mn), Online Sales, 2021–2031
Figure 12: Global Market Absolute $ Opportunity (US$ Mn), Super Markets, 2021–2031
Figure 13: Global Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 14: Global Market Value Share and BPS Analysis By Applications, 2021–2031
Figure 15: Global Market Y-o-Y Growth Comparison By Applications, 2021–2031
Figure 16: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, Sports Nutrition, 2021–2031
Figure 17: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, General Well-Being, 2021–2031
Figure 18: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, Immune & Digestive Health, 2021–2031
Figure 19: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, Bone & Joint Health, 2021–2031
Figure 20: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, Heart Health, 2021–2031
Figure 21: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, Disease Prevention, 2021–2031
Figure 22: Global Market Absolute $ Opportunity (US$ Mn) & Forecast, Weight Loss, 2021–2031
Figure 23: Global Market Attractiveness Analysis By Applications, 2021–2031
Figure 24: Global Market Value Share and BPS Analysis By Region, 2021–2031
Figure 25: Global Market Y-o-Y Growth Comparison By Region, 2021–2031
Figure 26: Global Market Attractiveness Analysis By Region, 2021–2031
Figure 27: North America Market Share Analysis (%) By Country, 2021 & 2031
Figure 28: North America Y-o-Y growth (%) By Country, 2021–2031
Figure 29: North America Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 30: North America Y-o-Y growth (%) By Product Type, 2021–2031
Figure 31: North America Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 32: North America Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 33: North America Market Share Analysis (%) By Applications, 2021 & 2031
Figure 34: North America Y-o-Y growth (%) By Applications, 2021–2031
Figure 35: North America Market Attractiveness Analysis By Product, 2021–2031
Figure 36: North America Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 37: North America Market Attractiveness Analysis, By Application, 2021–2031
Figure 38: North America Market Attractiveness Analysis, By Country, 2021–2031
Figure 39: Latin America Market Share Analysis (%) By Country, 2021 & 2031
Figure 40: Latin America Y-o-Y growth (%) By Country, 2021–2031
Figure 41: Latin America Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 42: Latin America Y-o-Y growth (%) By Product Type, 2021–2031
Figure 43: Latin America Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 44: Latin America Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 45: Latin America Market Share Analysis (%) By Applications, 2021 & 2031
Figure 46: Latin America Y-o-Y growth (%) By Applications, 2021–2031
Figure 47: Latin America Market Attractiveness Analysis By Product, 2021–2031
Figure 48: Latin America Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 49: Latin America Market Attractiveness Analysis, By Application, 2021–2031
Figure 50: Latin America Market Attractiveness Analysis, By Country, 2021–2031
Figure 51: Western Europe Market Share Analysis (%) By Country, 2021 & 2031
Figure 52: Western Europe Y-o-Y growth (%) By Country, 2021–2031
Figure 53: Western Europe Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 54: Western Europe Y-o-Y growth (%) By Product Type, 2021–2031
Figure 55: Western Europe Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 56: Western Europe Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 57: Western Europe Market Share Analysis (%) By Applications, 2021 & 2031
Figure 58: Western Europe Y-o-Y growth (%) By Applications, 2021–2031
Figure 59: Western Europe Market Attractiveness Analysis By Product, 2021–2031
Figure 60: Western Europe Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 61: Western Europe Market Attractiveness Analysis, By Application, 2021–2031
Figure 62: Western Europe Market Attractiveness Analysis, By Country, 2021–2031
Figure 63: Eastern Europe Market Share Analysis (%) By Country, 2021 & 2031
Figure 64: Eastern Europe Y-o-Y growth (%) By Country, 2021–2031
Figure 65: Eastern Europe Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 66: Eastern Europe Y-o-Y growth (%) By Product Type, 2021–2031
Figure 67: Eastern Europe Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 68: Eastern Europe Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 69: Eastern Europe Market Share Analysis (%) By Applications, 2021 & 2031
Figure 70: Eastern Europe Y-o-Y growth (%) By Applications, 2021–2031
Figure 71: Eastern Europe Market Attractiveness Analysis By Product, 2021–2031
Figure 72: Eastern Europe Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 73: Eastern Europe Market Attractiveness Analysis, By Application, 2021–2031
Figure 74: Eastern Europe Market Attractiveness Analysis, By Country, 2021–2031
Figure 75: APEJ Market Share Analysis (%) By Country, 2021 & 2031
Figure 76: APEJ Y-o-Y growth (%) By Country, 2021–2031
Figure 77: APEJ Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 78: APEJ Y-o-Y growth (%) By Product Type, 2021–2031
Figure 79: APEJ Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 80: APEJ Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 81: APEJ Market Share Analysis (%) By Applications, 2021 & 2031
Figure 82: APEJ Y-o-Y growth (%) By Applications, 2021–2031
Figure 83: APEJ Market Attractiveness Analysis By Product, 2021–2031
Figure 84: APEJ Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 85: APEJ Market Attractiveness Analysis, By Application, 2021–2031
Figure 86: APEJ Market Attractiveness Analysis, By Country, 2021–2031
Figure 87: Japan Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 88: Japan Y-o-Y growth (%) By Product Type, 2021–2031
Figure 89: Japan Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 90: Japan Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 91: Japan Market Share Analysis (%) By Applications, 2021 & 2031
Figure 92: Japan Y-o-Y growth (%) By Applications, 2021–2031
Figure 93: Japan Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 94: Japan Market Attractiveness Analysis By Product, 2021–2031
Figure 95: Japan Market Attractiveness Analysis, By Application,2021–2031
Figure 96: MEA Market Share Analysis (%) By Country, 2021 & 2031
Figure 97: MEA Y-o-Y growth (%) By Country, 2021–2031
Figure 98: MEA Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 99: MEA Y-o-Y growth (%) By Product Type, 2021–2031
Figure 100: MEA Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 101: APEJ Y-o-Y growth (%) By Distribution Channel, 2021–2031
Figure 102: MEA Market Share Analysis (%) By Applications, 2021 & 2031
Figure 103: MEA Y-o-Y growth (%) By Applications, 2021–2031
Figure 104: MEA Market Attractiveness Analysis By Product, 2021–2031
Figure 105: MEA Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 106: MEA Market Attractiveness Analysis, By Application, 2021–2031
Figure 107: MEA Market Attractiveness Analysis, By Country, 2021–2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
